Morphosys Ag (MOR.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2003 | 12-2002 | |
| Cash Flows From Operating Activities | ||
| Accounts receivable | 6,621 | -4,168 |
| Other Working Capital | 10,871 | 11,051 |
| Other Operating Activity | -11,679 | -22,128 |
| Operating Cash Flow | $5,813 | $-15,246 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -659 | -896 |
| Purchase Of Investment | -12,076 | -39,552 |
| Sale Of Investment | 14,832 | 29,054 |
| Other Investing Activity | -59 | -497 |
| Investing Cash Flow | $2,038 | $-11,891 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | -2,054 | 23,951 |
| Financing Cash Flow | $-2,054 | $23,951 |
| Exchange Rate Effect | 12 | 3 |
| Beginning Cash Position | 842 | 4,025 |
| End Cash Position | 6,652 | 842 |
| Net Cash Flow | $5,798 | $-3,186 |
| Free Cash Flow | ||
| Operating Cash Flow | 5,813 | -15,246 |
| Capital Expenditure | -682 | -922 |
| Free Cash Flow | 5,131 | -16,168 |